Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs

被引：0
作者：
Joshua Watson
Tianfang Wang
Kun-Lin Ho
Yuan Feng
Tanakamol Mahawan
Kevin K. Dobbin
Shaying Zhao
机构：
[1] University of Georgia,Institute of Bioinformatics
[2] University of Georgia,Department of Biochemistry and Molecular Biology, Institute of Bioinformatics
[3] University of Liverpool,Institute of Systems, Molecular and Integrative Biology
[4] University of Georgia,Department of Biostatistics
来源：
Breast Cancer Research | / 25卷
关键词：
Dog–human comparison; Canine mammary tumor subtyping; RNA-seq; Basal-like breast cancer; Estrogen receptor; Progesterone receptor; Prolactin receptor; Wnt signaling; Interferon-; response; PAM50 subtyping; Machine learning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 416 条
[1]  
Polyak K(2011)Heterogeneity in breast cancer J Clin Invest 121 3786-3788
[2]  
Ciriello G(2015)Comprehensive molecular portraits of invasive lobular breast cancer Cell 163 506-519
[3]  
Gatza ML(2012)Comprehensive molecular portraits of human breast tumours Nature 490 61-70
[4]  
Beck AH(2012)The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 486 346-352
[5]  
Wilkerson MD(2016)The somatic mutation profiles of 2433 breast cancers refines their genomic and transcriptomic landscapes Nat Commun 7 11479-95
[6]  
Rhie SK(2023)Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity Sci Adv 9 eadd6626-484
[7]  
Pastore A(2021)Genomic profiling of DVL-1 and its nuclear role as a transcriptional regulator in triple negative breast cancer Genes Cancer 12 77-71
[8]  
Zhang H(2023)Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer Cancer Res 83 471-494
[9]  
McLellan M(2020)A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations Breast Cancer Res 22 121-5056
[10]  
Yau C(2019)Mammary precancerous stem and non-stem cells evolve into cancers of distinct subtypes Can Res 79 61-29
12345678910